IRIS
DE VITA, Ferdinando
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 16.020
NA - Nord America 7.888
AS - Asia 6.500
SA - Sud America 1.034
AF - Africa 91
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 31.551
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 9.985
US - Stati Uniti d'America 7.664
SG - Singapore 2.214
IE - Irlanda 1.734
CN - Cina 1.405
HK - Hong Kong 1.015
IT - Italia 934
BR - Brasile 868
VN - Vietnam 778
UA - Ucraina 763
GB - Regno Unito 677
DE - Germania 615
FR - Francia 404
KR - Corea 387
FI - Finlandia 321
SE - Svezia 214
IN - India 173
CA - Canada 159
TR - Turchia 147
GR - Grecia 137
JP - Giappone 133
AR - Argentina 54
AT - Austria 46
NL - Olanda 46
BD - Bangladesh 44
MX - Messico 42
PL - Polonia 42
ID - Indonesia 39
EC - Ecuador 28
IQ - Iraq 27
BE - Belgio 25
ES - Italia 22
ZA - Sudafrica 22
PK - Pakistan 20
CL - Cile 18
VE - Venezuela 16
MA - Marocco 14
PE - Perù 14
SC - Seychelles 13
CO - Colombia 12
CZ - Repubblica Ceca 11
AL - Albania 10
PH - Filippine 10
SA - Arabia Saudita 10
IL - Israele 9
PY - Paraguay 9
TH - Thailandia 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
BO - Bolivia 7
DO - Repubblica Dominicana 7
KZ - Kazakistan 7
NP - Nepal 7
TN - Tunisia 7
UY - Uruguay 7
AZ - Azerbaigian 6
EG - Egitto 6
IR - Iran 6
KE - Kenya 6
NZ - Nuova Zelanda 6
AU - Australia 5
EU - Europa 5
JO - Giordania 5
LB - Libano 5
LT - Lituania 5
MY - Malesia 5
PT - Portogallo 5
SN - Senegal 5
CG - Congo 3
ET - Etiopia 3
HN - Honduras 3
JM - Giamaica 3
KG - Kirghizistan 3
LU - Lussemburgo 3
LV - Lettonia 3
RS - Serbia 3
TW - Taiwan 3
AO - Angola 2
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
CY - Cipro 2
DZ - Algeria 2
LK - Sri Lanka 2
MK - Macedonia 2
OM - Oman 2
PA - Panama 2
QA - Qatar 2
RO - Romania 2
SV - El Salvador 2
UG - Uganda 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CH - Svizzera 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
Totale 31.534
Salva come PNG Salva come JPEG
Città #
Moscow 3.641
Dublin 1.726
Jacksonville 1.178
Hong Kong 1.008
Santa Clara 971
San Jose 962
Singapore 915
Chandler 805
Seoul 371
Ashburn 308
Princeton 244
Ho Chi Minh City 239
Medford 216
New York 193
Hanoi 186
Hefei 168
Beijing 156
Naples 149
Caserta 143
Ann Arbor 142
Roxbury 141
Boardman 140
Bremen 134
San Mateo 125
Bengaluru 122
Helsinki 116
Munich 100
Elora 97
Wilmington 97
Dallas 85
Los Angeles 79
Woodbridge 75
São Paulo 69
The Dalles 66
Nanjing 65
Des Moines 53
Dong Ket 52
Cambridge 51
Nuremberg 49
Napoli 46
Milan 41
Jinan 37
Da Nang 36
Rome 36
Mountain View 30
Rio de Janeiro 29
Haiphong 27
Amsterdam 26
Council Bluffs 26
Kraków 26
Brussels 24
Houston 24
Tianjin 24
Belo Horizonte 23
Vienna 23
Orem 22
Tokyo 21
Chicago 20
Curitiba 19
Memphis 19
Norwalk 19
Aversa 18
Hangzhou 18
Turku 18
Zhengzhou 18
Atlanta 17
Biên Hòa 17
Changsha 16
Shenyang 16
Toronto 16
Brasília 15
Chennai 15
Düsseldorf 15
Guangzhou 15
Jakarta 15
Aiello Del Sabato 14
Hải Dương 14
Montreal 14
Shanghai 14
London 13
Nanchang 13
San Francisco 13
Thái Nguyên 13
Auburn Hills 12
Ottawa 12
Thái Bình 12
Brooklyn 11
Guarulhos 11
Hillsboro 11
Istanbul 11
Lanzhou 11
Manchester 11
Porto Alegre 11
Taizhou 11
Brno 10
Ercolano 10
Frankfurt am Main 10
Guayaquil 10
Lima 10
Salvador 10
Totale 16.556
Salva come PNG Salva come JPEG
Nome #
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis 209
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy. 206
ONCOLOGIA MEDICA 206
MicroRNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib 194
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients 189
Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma—a pilot study. Curr Oncol 21, 3, june 2014 125-133 185
Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis 183
Adjuvant chemoradiotherapy in patients with stage III-IV radically resected gastric cancer: a pilot study 183
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience 183
A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant 182
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer 181
A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC). 177
Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: A propensity score-matched analysis 176
Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis 173
Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors 173
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study) 172
Amifostine: a selective cytoprotective agent of normal tissues from chemo-radiotherapy induced toxicity (Review) 172
CD 26-positive/CD 326-negative circulating cancer cells as prognostic markers for colorectal cancer recurrence 171
Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience 171
Microsatellite Status Detection in Gastrointestinal Cancers: PCR/NGS Is Mandatory in Negative/Patchy MMR Immunohistochemistry 171
Clinical management of advanced gastric cancer: Role of new molecular drugs. 167
Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors. 167
A true splenic cyst producing carboydrate antigen 19-9 and cancer antigen 50 and 125,but not interleukin 10 166
Analysis of neurothelin expression in neoplastic cells derived from gastrointestinal tract tumors 166
Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma. 165
Antitumor activity of ZD6474, a vascular endothelial growth factor-2 and epidermal growth factor receptor small molecule tyrosine kinase inhibitor, in combination with SC-236, a cyclooxygenase-2 inhibitor 163
Different Biomarkers address different colorectal cancer stem cell populations: who's the killer? 162
Naples Prognostic Score Predicts Tumor Regression Grade in Resectable Gastric Cancer Treated with Preoperative Chemotherapy 162
Combined CD133/CD44 Expression as a Prognostic Indicator of Disease-Free Survival in Patients With Colorectal Cancer. 161
Liquid Biopsy at Home: Delivering Precision Medicine for Patients with Cancer During the Covid-19 Pandemic 161
Behavior of circulating CD4+CD25+FOXP3* regulatory T cells in colon cancer patients undergoing surgery 160
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC 160
Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment 159
Pancreatic fistula following pancreatoduodenectomy. Evaluation of different surgical approaches in the management of pancreatic stump. Literature review. 158
A true splenic cyst producing carbohydrate antigen 19-9 and cancer antigens 50 and 125, but not interleukin 10 157
Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival 156
antitumor activity of zd6474, a VEGFR-2 and EGFR small molecule tyrosine kinase inhibitor in combination with SC-236, a cicloxigenase-2 inhibitor 153
Predictive biomarkers along gastric cancer pathogenetic pathways 153
Conversion chemotherapy followed by epatic resection in colorectal cancer with initially unresectable liver-limited metastases 152
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer 151
Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review. 151
An intramedullary "flame" recognized as being an intramedullary spinal cord metastasis from esophageal cancer 151
Treatment of gastric cancer. 150
Analysis of interleukin-2/interleukin-2 receptor system in advanced non-small-cell lung cancer 150
Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome 149
Adult Wilms' tumor: a case report 148
Inflammatory and nutritional status is a predictor of long-term outcome in patients undergoing surgery for gastric cancer. Validation of the Naples prognostic score. 148
Clinical practice use of liquid biopsy to identify RAS/BRAF mutations in patients with metastatic colorectal cancer (mCRC): A single institution experience 146
DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer 145
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy 145
Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer 145
Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative Setting 145
Immunotherapy in Penile Squamous Cell Carcinoma: Present or Future? Multi-Target Analysis of Programmed Cell Death Ligand 1 Expression and Microsatellite Instability 144
Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: a propensity score-matched analysis 144
Correlation between efficacy and skin rash occurrence following treatment with the epidermal growth factor receptor inhibitor cetuximab: a single institution retrospective analysis 144
Novel Therapeutic Opportunities in Neoadjuvant Setting in Urothelial Cancers: A New Horizon Opened by Molecular Classification and Immune Checkpoint Inhibitors 144
Discrepancy of p16 immunohistochemical expression and HPV RNA in penile cancer. A multiplex in situ hybridization/immunohistochemistry approach study 144
A rare case of extraovarian primary peritoneal carcinoma in a 72 year-old woman 143
Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM) 141
Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma 141
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors 141
Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: A randomised study by the Southern Italy Cooperative Oncology Group 140
A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases. 140
Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs 140
HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study 139
Farmacogenomica e cancro colorettale 139
Is complete mesocolic excision with central vascular ligation safe and effective in the surgical treatment of right-sided colon cancers ? A prospective study. 139
Anthracycline-induced cardiotoxicity: monitoring and prevention of the lesion 138
Hepatoid carcinoma colliding with a liposarcoma of the left colon serosa presenting as an abdominal mass 137
Analysis of recovery time indexes in 5-fluorouracil-treated cancer patients 137
The over-the-scope-clip (OTSC) system is effective in the treatment of chronic esophago-jejunal anastomotic leakage 137
Atypycal presentation of Merkel cell carcinoma positive to polyomavirus DNA detection: experience from a single center 136
Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial 135
Complete response to preoperative chemoradiation and survival in esophageal cancer : a pooled analysis of three singe-institution phase II trials. 135
Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study 134
Triple-Negative Breast Cancers: Systematic Review of the Literature on Molecular and Clinical Features with a Focus on Treatment with Innovative Drugs 134
Assessment of the DNA Mismatch Repair System Is Crucial in Colorectal Cancers Necessitating Adjuvant Treatment: A Propensity Score-Matched and Win Ratio Analysis 133
Adjuvant chemotherapy of gastric cancer: which regimen? 133
p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate 133
Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAF wild-type metastatic colorectal cancer in the CAPRI 2-GOIM trial 132
Serum interleukin-10 is an independent prognostic factor in advanced solid tumors 132
TRATTAMENTO MULTIMODALE DEL CA ESOFAGEO. NOSTRA ESPERIENZA 131
Increased circulating levels of vascular endothelial growth factor C can predict outcome in resectable gastric cancer patients 131
Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells 130
Cardiotossicità da antracicline: attualità e prospettive 130
PROSPETTIVE DELLA TERAPIA NEOADIUVANTE NEL CANCRO ESOFAGEO AVANZATO 130
Panitumumab plus trifluridine/tipiracil as anti‐EGFR rechallenge therapy in patients with refractory RAS wild‐type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial 129
Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies 129
Immune-Based Therapy in Triple-Negative Breast Cancer: From Molecular Biology to Clinical Practice 128
Presence of tumor deposits is a strong indicator of poor outcome in patients with stage III colorectal cancers undergoing radical surgery 128
Vertebral carcinomatosis eleven years after advanced gastric cancer resection: A case report. 128
PERSPECTIVES OF THE NEOADJUANT THERAPY IN ADVANCED ESOPHAGEAL CARCINOMA 128
Pegylated liposomal doxorubicin: pharmacologic and clinical evidence of potent antitumor activity with reduced anthracyclina-induced cardiotoxicity (review) 128
TRASTUZUMAB RESISTANCE IN BREAST CANCER 128
The lymph node ratio is a powerful prognostic factor of node-positive colon cancers undergoing potentially curative surgery. 127
Serum vascular endothelial growth factor (VEGF)levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer 127
Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: Relationship with prognosis 127
Perioperative Treatment in Resectable Gastric Cancer: Current Perspectives and Future Directions 127
Integrated therapy in localized gastric cancer: targeted and tailored approach. 126
Phosphatidylinositol 3-kinase (PI3Ka)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells 126
Totale 15.076
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.325
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.325
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202199 0 0 0 0 0 0 0 0 0 0 0 99
2021/20221.453 134 10 16 24 528 8 29 48 51 61 125 419
2022/20233.327 429 61 45 262 363 256 15 194 1.587 14 55 46
2023/20241.307 107 36 59 117 444 166 11 31 16 19 95 206
2024/20253.993 37 109 38 110 618 512 491 367 567 549 306 289
2025/202616.991 593 826 815 843 1.354 9.303 792 931 722 435 233 144
Totale 32.147